Condition

Dyslipidemia clinical trials and research

• 30Clinical trials
• 11NIH research projects
• 1New in 30 days
• 11Countries

Newest Dyslipidemia clinical trials

All recruiting trials (30)

• Observational study of achieving LDL targets with Rovazet tablets in dyslipidemia

  This study follows patients with dyslipidemia who are prescribed Rovazet to see how well reaching LDL targets works in routine care over 48 weeks.

  Recruiting HK inno.N Corporation · Seoul · NCT07924345

• Early Triple Lipid-Lowering Therapy After ACS

  This trial tests whether adding bempedoic acid to high-intensity statin and ezetimibe within 72 hours after PCI helps more adults with acute coronary syndrome reach LDL-C goals than the standard two-drug approach.

  Recruiting Phase 4 Taipei Medical University Hospital · Taipei, Taipei City · NCT07824323

• Kodo Millet Porridge and Gut Health in Overweight and Obese Adults

  This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.

  Recruiting Jss Medical College, Jss Academy of Higher Education and Research · Mysore, Karnataka · NCT07703371

• Taiwan green propolis for MASLD and lipid/metabolic issues

  This study tests whether Taiwan green propolis capsules can improve blood lipids and body fat in adults with MASLD compared to a placebo over 12 weeks.

  Recruiting Taipei Medical University · Dalin · NCT07692438

• EHR-guided LDL cholesterol optimization after a heart event

  A pharmacist-guided program using electronic health records to help adults in Alberta reach LDL goals after a heart event by adjusting medications and ordering tests.

  Recruiting at 2 sites University of Alberta · Edmonton, Alberta and 1 other locations · NCT07685639

• Two-drug interaction study of UIC202601 and UIC202602 in healthy adults

  This study tests whether combining two investigational drugs changes how they behave in the body and whether the combination is safe in healthy volunteers.

  Recruiting Phase 1 Korea United Pharm. Inc. · Anyang, Manan-gu · NCT07682948

• Polypill Approach for Multiple Cardiovascular Risk Factors

  Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.

  Recruiting at 5 sites China Medical University, China · Zhengzhou, Henan and 14 other locations · NCT07679828

• Goal-commitment coaching to boost proactive health actions in adults with hypertension, diabetes, or high cholesterol

  This project will try a goal-commitment behavioral program to see if it helps adults with hypertension, diabetes, or high cholesterol adopt more proactive health habits.

  Recruiting Huazhong University of Science and Technology · Wuhan, Hubei · NCT07552571

• Moderate-Intensity Statin + Ezetimibe vs High-Intensity Statin in CKD with ASCVD

  In adults with chronic kidney disease and established cardiovascular disease, this study tests whether a moderate-intensity statin plus ezetimibe can match the benefits of a high-intensity statin alone over three years.

  Recruiting Yonsei University · Seoul · NCT07524101

• Structured management of adult cardiovascular risk factors in outpatient care

  This project will try a structured clinic approach to managing blood pressure, cholesterol, diabetes, and weight in adults with cardiovascular risk factors to see if it improves risk control and outcomes.

  Recruiting Universidad Católica San Antonio de Murcia · Santiago, Santiago Metropolitan · NCT07447362

• Digital Care for holistic health in older adults with diabetes and multiple conditions

  This study tests a digital care program to help adults 50+ with type 2 diabetes and other chronic diseases improve disease control, self-management, mood, and quality of life.

  Recruiting Chang Gung University of Science and Technology · New Taipei City, Wugu District · NCT07310849

• Intermittent cottonseed oil intake to improve cholesterol and metabolic risk

  This trial will test whether taking cottonseed oil three times a week at two different doses can improve fasting and after-meal blood lipids and other risk markers in adults with high cholesterol or who are overweight.

  Recruiting University of Georgia · Athens, Georgia · NCT07246408

• Digital tool for doctors to prescribe exercise for people with cardiovascular risk factors

  This project will test whether a new digital tool helps doctors create personalized exercise plans for adults with cardiovascular risk factors.

  Recruiting at 2 sites University of Connecticut · Farmington, Connecticut and 2 other locations · NCT07238556

• Personalized daily step targets to change body fat and cardiometabolic risk in adults with overweight or obesity

  This project will test if giving personalized daily step targets based on body fat helps adults with overweight or obesity change body composition and lower cardiometabolic risk.

  Recruiting Kennesaw State University · Kennesaw, Georgia · NCT07221279

• Integrated, nurse-led digital remote monitoring for cardiovascular risk management

  This observational program tests a nurse-led, at-home telemonitoring care pathway to help adults with ASCVD, hypertension, or dyslipidemia better manage blood pressure and cholesterol.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT07208331

• Observational register of adults with diabetes and endocrine/metabolic disorders

  This study will collect medical information from adults with diabetes or related metabolic and endocrine conditions to see how markers relate to disease severity and progression.

  Recruiting IRCCS San Raffaele · Milan, Italy · NCT07206875

• Comparing safety and how the body handles UIC202502 and UIC202505 in healthy adults.

  This trial will test whether UIC202502 and UIC202505, given alone or together, are safe and how they are processed by the body in healthy adults.

  Recruiting Phase 1 Korea United Pharm. Inc. · Seoul, Gwanak-gu · NCT07162441

• Intensive versus standard care and education for cholesterol management in people with hypertension and diabetes

  This project will test whether a structured, intensive dyslipidemia management and education program helps adults with hypertension and diabetes improve their blood lipid levels.

  Recruiting Saint Vincent's Hospital, Korea · Gyeonggi-do, Suwon-si · NCT07045623

• Heart, kidney, and metabolic health in Shanghai community residents

  This follow-up will track people from the STONE cohort to see if changes in metabolic risk factors over time relate to heart and kidney outcomes.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT07043166

• AZD4954 safety and dosing in adults with or without high lipoprotein(a) and in people with dyslipidemia

  This trial will test single and repeated doses of AZD4954 in healthy adults and adults with high Lp(a) or dyslipidemia to see how safe the drug is and how it behaves in the body.

  Recruiting at 6 sites Phase 1 AstraZeneca · Glendale, California and 5 other locations · NCT06980428

• Using wearable devices to improve health in high-risk stroke patients

  This study is testing if smart wearable devices can help high-risk stroke patients manage their health better by reminding them to take medication, monitor their heart rate, and encourage exercise.

  Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT06935513

• Digital heart-health app and lifestyle program for adults with heart disease or high-risk diabetes

  This program will test whether adding a digital heart-health app and lifestyle support to usual care helps adults on statins with established heart disease or high-risk type 2 diabetes lower their cardiovascular risk.

  Recruiting University of Toronto · Toronto, Ontario · NCT06919302

• Substituting high- with low-ultra-processed soy protein foods within a guideline-based diet for cardiometabolic health

  This study tests whether a 12-week digital diet program with extra fruits and vegetables, combined with either low- or high-ultra-processed soy protein foods, can lower systolic blood pressure in adults with hypertension and obesity, about half of whom have type 2 diabetes.

  Recruiting University of Toronto · Toronto, Ontario · NCT06907862

• Evaluating a new drug for Type 2 Diabetes and Dyslipidemia

  This study is testing a new drug called CMG190303 to see if it can help adults with Type 2 Diabetes and high cholesterol feel better compared to standard treatments.

  Recruiting at 24 sites Phase 3 CMG Pharmaceutical Co. Ltd · Anyang and 23 other locations · NCT06772168

• Investigating body fat distribution and its impact on metabolic diseases in Japanese adults

  This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.

  Recruiting Osaka Metropolitan University · Sakai, Osaka · NCT06694012

• Program to prevent young onset diabetes using genetic and clinical assessments

  This study is testing a program that uses genetic and health checks to help young adults at risk of diabetes prevent the disease and learn more about their health.

  Recruiting Asia Diabetes Foundation · Hong Kong · NCT06693934

• Understanding rare lipid disorders and their effects over time

  This study is trying to understand how rare lipid disorders change over time and how they respond to treatments in people aged 10 and older.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06676046

• Giving JW0104 together with C2402 for people with high blood pressure and high cholesterol

  This study will test whether taking JW0104 with C2402 helps people who have both hypertension and dyslipidemia control their blood pressure and cholesterol.

  Recruiting Phase 3 JW Pharmaceutical · Seoul · NCT06643130

• Comparing the effects of cottonseed oil and matched PUFA on cholesterol levels

  This study is testing whether drinking meal replacement shakes with cottonseed oil can help lower cholesterol levels in adults at risk for heart disease compared to shakes with a different type of healthy fat.

  Recruiting University of Georgia · Athens, Georgia · NCT06382298

• Effect of choline fenofibrate on carotid atherosclerosis in type 2 diabetes patients

  This study is testing if a medication called choline fenofibrate can help slow down the buildup of plaque in the arteries of Korean patients with type 2 diabetes and high cholesterol.

  Recruiting Phase 4 Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT05365425

NIH-funded research (11)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Reducing harmful blood fats with a small sugar from human milk

  This grant explores whether a human milk sugar called 3’SL can lower remnant cholesterol and inflammation to reduce heart disease risk in people with atherosclerosis.

  NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11450156

• Potential Effects of a Plasticizer on Dyslipidemia and Atherosclerosis

  A study in young models looks at how certain plastic chemicals might influence cholesterol and artery disease through a key liver receptor.

  NIH research University of Nebraska Kearney · Kearney, United States · NIH-11422558

• Fabkin, a New Hormone Complex, and Its Role in Lipids and Inflammation Driving Atherosclerosis

  A new hormone complex called Fabkin is being studied to see if it links fat metabolism and inflammation in atherosclerosis so future treatments could target both problems.

  NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11406165

• Diet-Driven Lipid Imbalance and Skin Inflammation Linked to Self-Lipid–Specific T Cells

  This project looks at how diet-related changes in lipids may trigger immune cells that recognize self-lipids, potentially worsening skin inflammation in psoriasis.

  NIH research Northwestern University · Chicago, United States · NIH-11352037

• Liver energy imbalance (NADH) and the driver ChREBP in fatty liver and high blood fats

  This project aims to lower a liver chemical called NADH to see if that reduces liver fat and improves blood fat levels for people with alcoholic or non-alcoholic fatty liver disease.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11247909

• Blood fats and diabetic eye disease

  This project looks at how changes in certain fats in the blood and retina may cause or worsen diabetic retinopathy and whether targeting those fat pathways could help protect vision for people with diabetes.

  NIH research University of Oklahoma Hlth Sciences Ctr · Oklahoma City, United States · NIH-11172544

• Investigating the effects of PFAS exposure on cholesterol levels in volunteer firefighters

  This study is looking at how certain chemicals found in firefighting gear and foams might affect cholesterol levels in volunteer firefighters, helping us understand their health risks better and find ways to keep them safer.

  NIH research Rutgers Biomedical and Health Sciences · Newark, UNITED STATES · NIH-11042697

• Understanding how NADH levels affect fatty liver disease and cholesterol levels

  This study is looking at how high levels of a substance called NADH in the liver might lead to fatty liver disease and problems with cholesterol, and it's for anyone interested in understanding how these conditions develop and finding new ways to improve liver health.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-10989939

• Investigating the role of APOC3 in heart and kidney diseases related to diabetes

  This study is looking at how a protein called APOC3 affects heart and kidney problems in people with diabetes, and it hopes to find out if blocking this protein can help prevent kidney disease, especially in those with both diabetes and kidney issues, which might raise the risk of heart disease.

  NIH research University of Washington · Seattle, United States · NIH-10774240

• Developing new treatments to target a protein linked to heart disease

  This study is looking at how a protein called ApoC-III affects heart health, especially for people who have high cardiovascular risk even when their LDL cholesterol is low, and the researchers are trying to find new treatments that can help clear this protein from the blood to improve heart health.

  NIH research Imetabolic Biopharma Corporation · Tempe, United States · NIH-10760187

• How air pollution affects cholesterol levels and heart disease through gut bacteria

  This study is looking at how breathing in tiny air pollution particles might affect your cholesterol and heart health by changing the bacteria in your gut, and it aims to find new ways to help people at risk for heart problems due to air pollution.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-10475819

Related topics

Quick answers

How many Dyslipidemia clinical trials are recruiting right now?

30, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in South Korea (8 trials), United States (6 trials), China (4 trials), Taiwan (3 trials), Canada (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 4: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →